MS drug trial offers new hope for stroke recovery
NCT ID NCT07275515
Summary
This study is testing if a drug already used for multiple sclerosis (diroximel fumarate) can safely reduce dangerous brain swelling that occurs after a bleeding stroke. Researchers believe calming brain inflammation with this drug may help patients recover better. The trial will involve 192 adults in France who have recently had a stroke, comparing the drug to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Lille
Lille, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.